Clinical Trials Browser

Phase 2 × Recurrence × durvalumab × Clear all

NCT03999710 2025-11-28

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Recurrence

NCT03723967 2024-04-22

FRAIL-IMMUNE

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT04015739 2022-08-17

BOLD

Phase 2 Unknown

Carcinoma, Ovarian Epithelial, Recurrence

NCT02207530 2020-09-29

Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

112 enrolled 20 charts

Head and Neck Neoplasms, Recurrence

NCT02319044 2020-09-29

Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck

Phase 2 Completed

267 enrolled 27 charts

Head and Neck Neoplasms, Recurrence

NCT03000452 2018-10-16

FUSION-MM-005

Phase 2 Completed

18 enrolled 16 charts

Multiple Myeloma, Recurrence